Noah Bindman is currently the Associate Director of ADC Engineering at Pfizer, where they develop new antibody-drug conjugates to improve efficacy and reduce toxicity. Previously, they served as a Principal Scientist at Seagen and a NIH Postdoctoral Fellow, specializing in Developmental, Reproductive, and Endocrine Toxicology. Noah holds a PhD in Chemical Biology from the University of Illinois at Urbana-Champaign, where they devised innovative techniques for studying lanthipeptides. Their extensive experience in biopharma reflects a deep passion for advancing patient care through drug development and scientific communication.
This person is not in the org chart
This person is not in any teams
This person is not in any offices